Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Fitness to practise

Reported fitness to practise concerns have risen every quarter in the past year

Fitness-to-practise case concerns reported to the General Pharmaceutical Council (GPhC) have risen for the fourth quarter in a row.

Figures presented to the GPhC’s Council meeting on 7 June 2018 showed that there were 462 concerns reported in quarter one of the financial year 2017–2018. This rose to 563 concerns in quarter two, 611 in quarter three, and 667 in the final quarter of the year.

In the council papers, the GPhC said that despite the rise, its total caseload — the number of fitness-to-practise cases it is working on at any one time — had only increased by 10.2%.

Claire Bryce-Smith, GPhC director of insight, intelligence and inspection, said there had been a general upward trend in the number of concerns received by the GPhC, but that there was “no one single factor, or one that is immediately identifiable, that gives an indication as to why this is happening”.

“Importantly, there are no new trends in what we are receiving or who we are receiving concerns from, so establishing a reason for the increase is not straightforward,” she said.

Bryce-Smith said there would “inevitably be a range of factors” influencing the rise, such as people becoming aware of the regulator’s online concerns form, “which makes the process of raising a concern more straightforward”.

The regulator is monitoring the number, nature and source of concerns on a monthly basis “to ensure we are able to identify any trends, factors or reasons that we can, more generally, take action on,” she added.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204993

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Physicochemical Principles of Pharmacy

    Physicochemical Principles of Pharmacy

    This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.

    £48.00Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • General Pharmaceutical Council

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.